Innovacell Inc. (504A.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

JPY 25.56B

MomentumView details →

1D Return

−1.22%

YTD Return

—

RSI (14)

52.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

JPY 25.56B

RSI (14)

52.0

MomentumView details →

1D Return

−1.22%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

28.49x

Quick Ratio

28.43x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

Inovacell obtained a domestic patent for a method for obtaining induced smooth muscle cells, related to 'ICEF16' targeting fecal incontinence.8d ago

Similar companies

HEALIOS K.K.4593.T MIZUHO MEDY CO.,LTD.4595.T StemRIM Inc.4599.T Fuso Pharmaceutical Industries,Ltd.4538.T SEIKAGAKU CORPORATION4548.T Daito Pharmaceutical Co.,Ltd.4577.T Find similar companies →

Latest newsMore news →

Inovacell obtained a domestic patent for a method for obtaining induced smooth muscle cells, related to 'ICEF16' targeting fecal incontinence.8d ago